Table 4.

Patient-Reported Outcome Scores ^a

	Baseline	1 mo	3 mo	6 mo
KOOS–Pain
PRP	50.90 ± 11.64	75.72 ± 14.54	77.32 ± 17.99	80.38 ± 16.07
MFAT	51.48 ± 9.78	73.80 ± 11.48	81.48 ± 15.24	81.61 ± 16.37
KOOS–Symptoms
PRP	53.92 ± 18.86	72.24 ± 17.85 b	76.19 ± 17.78	76.38 ± 17.87
MFAT	49.64 ± 17.38	63.10 ± 13.01 b	74.05 ± 17.49	75.37 ± 19.45
KOOS-ADL
PRP	58.63 ± 15.20	82.45 ± 15.79	83.63 ± 16.86	87.38 ± 13.27
MFAT	62.11 ± 16.99	80.54 ± 12.12	88.19 ± 12.52	88.85 ± 15.05
KOOS–Sport/Rec
PRP	28.23 ± 19.35	60.16 ± 26.31	64.17 ± 23.05	64.52 ± 27.67
MFAT	28.50 ± 19.57	53.83 ± 19.99	63.67 ± 22.05	65.86 ± 25.60
KOOS-QoL
PRP	31.45 ± 14.39	58.47 ± 22.80	59.17 ± 23.14	63.71 ± 21.97
MFAT	30.21 ± 16.98	50.63 ± 15.51	65.00 ± 18.76	68.10 ± 21.41
VAS-ADL
PRP	50.10 ± 21.73	22.97 ± 22.43	20.57 ± 21.29	19.74 ± 21.65
MFAT	48.97 ± 22.46	21.57 ± 18.02	16.00 ± 18.83	14.59 ± 19.80
Tegner
PRP	3.06 ± 1.55	4.06 ± 1.73	3.93 ± 1.14	4.00 ± 1.59
MFAT	3.00 ± 2.05	3.73 ± 1.39	4.23 ± 1.38	4.34 ± 1.47

^a Data are reported as mean ± SD. ADL, Activities of Daily Living; KOOS, Knee injury and Osteoarthritis Outcome Score; MFAT, microfragmented adipose tissue; PRP, platelet-rich plasma; QoL, Quality of Life; Sport/Rec, Sport and Recreation; VAS, visual analog scale.

^b Statistically significant difference (P = .03).